cost of asthma treatment
|
Rigel says Pfizer returns asthma therapy rights
Reuters A year later, Pfizer identified R343 as the lead product candidate for treatment of allergic asthma. Rigel said it will assume the development of R343 and expects to design a mid-stage clinical trial later this year. "It is rare in our business that … Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release) Pfizer returns asthma drug development to RigelForbes Pfizer Hands Back Rigel DrugXconomy FierceBiotech all 39 news articles » |
asthma medications side effects
